Overview

A Study to Assess the Safety and Tolerability of Surgical Implant of MSK-DA01 Cells for Advanced Parkinson's Disease

Status:
Not yet recruiting

Trial end date:
2023-04-01

Target enrollment:

Participant gender:

Summary

The main purpose of this study is to test the safety and tolerability of the study intervention, MSK-DA01, which will be implanted into the brain of study participants during a surgical procedure. This study is the first time that MSK-DA01 is being tested in people.

Phase:

Phase 1

Details

Lead Sponsor:

Memorial Sloan Kettering Cancer Center

Treatments:

Immunosuppressive Agents